Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtriCure, Inc. - Common Stock (NQ:ATRC)

35.23 -0.88 (-2.45%)
Streaming Delayed Price Updated: 2:01 PM EDT, Sep 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 206,800
Open 36.04
Bid (Size) 35.16 (4)
Ask (Size) 35.29 (1)
Prev. Close 36.11
Today's Range 34.57 - 36.04
52wk Range 25.94 - 43.11
Shares Outstanding 45,882,449
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AtriCure Announces the Launch of the cryoXT™ Device for Post-Operative Pain Management Following Amputation
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
From AtriCure, Inc.
Via Business Wire

Performance

YTD
+15.9%
+15.9%
1 Month
-0.8%
-0.8%
3 Month
+5.5%
+5.5%
6 Month
+3.8%
+3.8%
1 Year
+34.2%
+34.2%

More News

Read More
AtriCure (ATRC) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Earnings Scheduled For July 29, 2025
Via Benzinga
Earnings Scheduled For April 29, 2025
Via Benzinga
AtriCure Earnings Preview
Via Benzinga
Earnings Scheduled For February 12, 2025
Via Benzinga
AtriCure (ATRC) Q2 Revenue Jumps 17%
Via The Motley Fool
Why LendingClub Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
What's going on in today's after hours session
Via Chartmill
Expert Outlook: AtriCure Through The Eyes Of 5 Analysts
Via Benzinga
AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce Second Quarter 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
From AtriCure, Inc.
Via Business Wire
14 Analysts Assess AtriCure: What You Need To Know
Via Benzinga
Visa To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
AtriCure Reports First Quarter 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure Announces First Use of the AtriClip PRO-Mini® Device
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce First Quarter 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
11 Analysts Have This To Say About AtriCure
Via Benzinga
AtriCure to Host Analyst & Investor Day on March 26, 2025
From AtriCure, Inc.
Via Business Wire
AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results
From AtriCure, Inc.
Via Business Wire

Frequently Asked Questions

Is AtriCure, Inc. - Common Stock publicly traded?
Yes, AtriCure, Inc. - Common Stock is publicly traded.
What exchange does AtriCure, Inc. - Common Stock trade on?
AtriCure, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for AtriCure, Inc. - Common Stock?
The ticker symbol for AtriCure, Inc. - Common Stock is ATRC on the Nasdaq Stock Market
What is the current price of AtriCure, Inc. - Common Stock?
The current price of AtriCure, Inc. - Common Stock is 35.23
When was AtriCure, Inc. - Common Stock last traded?
The last trade of AtriCure, Inc. - Common Stock was at 09/10/25 02:01 PM ET
What is the market capitalization of AtriCure, Inc. - Common Stock?
The market capitalization of AtriCure, Inc. - Common Stock is 1.62B
How many shares of AtriCure, Inc. - Common Stock are outstanding?
AtriCure, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.